Nevanimibe hydrochloride (Synonyms: PD-132301 hydrochloride; ATR101 hydrochloride) |
Katalog-Nr.GC65200 |
Nevanimibe-Hydrochlorid (PD-132301-Hydrochlorid) ist ein oral aktiver und selektiver Acyl-Coenzym A:Cholesterin-O-Acyltransferase-1 (ACAT1)-Hemmer mit einem EC50-Wert von 9 nM. Nevanimibe-Hydrochlorid hemmt ACAT2 mit einem EC50-Wert von 368 nM. Nevanimibe-Hydrochlorid induziert Zellapoptose und hat das Potenzial fÜr Nebennierenrindenkrebs.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 133825-81-7
Sample solution is provided at 25 µL, 10mM.
Nevanimibe hydrochloride (PD-132301 hydrochloride) is an orally active and selective acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) inhibitor with an EC50 of 9 nM. Nevanimibe hydrochloride inhibits ACAT2 with an EC50 of 368 nM. Nevanimibe hydrochloride induces cell apoptosis and has the potential for adrenocortical cancer[1].
Coincubation of Nevanimibe hydrochloride (PD-132301 hydrochloride; ATR101 hydrochloride; 3 nM-30 μM) and Cholesterol markedly increases toxicity in a dose-dependent manner, where 3 nM Nevanimibe in the presence of 60 μg/mL Cholesterol reduces survival by 60% after 24 hours. All doses of Nevanimibe (3 nM-30 μM) induces cytoxicity in the presence of Cholesterol, whereas treatment with Cholesterol in the absence of Nevanimibe has no effect on cell viability[1].
[1]. LaPensee CR, et al. ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs. Endocrinology. 2016 May;157(5):1775-88.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *